Effekt og sikkerhed ved akut koronarsyndrom (AKS) Fase 3 TRITON- undersøgelsen sammenlignede Efient (prasugrel) med clopidogrel, både administreret i kombination med ASA og anden standardterapi.
Efficacy and Safety in Acute Coronary Syndrome (ACS) The phase 3 TRITON study compared Efient (prasugrel) with clopidogrel, both co-administered with ASA and other standard therapy.